Non-obstructive Hypertrophic Cardiomyopathy

• CLINICAL_TRIALS trial_result · 2026-02-20
  Clinical Trial Update: A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM [Phase 2, Phase 3]

  This clinical trial update notes the completion of a long-term safety extension study of mavacamten in adults who completed MAVERICK-HCM or …

• CLINICAL_TRIALS trial_result · 2026-02-11
  Clinical Trial Update: Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy [NA]

  A clinical trial evaluating personalized accelerated pacing in symptomatic non-obstructive hypertrophic cardiomyopathy has been terminated.

• CLINICAL_TRIALS research · 2026-02-09
  Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy [Phase 2]

  A Phase 2 clinical trial update reports that Ninerafaxstat is being studied for efficacy and safety in symptomatic non-obstructive hypertrop…

• CLINICAL_TRIALS trial_result · 2025-11-14
  Clinical Trial Update: A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy [Phase 3]

  Phase 3 study of mavacamten for non-obstructive hypertrophic cardiomyopathy has completed.

• CLINICAL_TRIALS research · 2025-03-20
  Clinical Trial Update: Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy [Phase 4]

  Phase 4 clinical trial evaluating the combination of bisoprolol and verapamil for symptomatic non-obstructive hypertrophic cardiomyopathy, c…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-03-05
  Clinical Trial Update: A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy [Phase 2]

  Phase II clinical trial enrolling to evaluate HRS-1893 in non-obstructive hypertrophic cardiomyopathy.

• CLINICAL_TRIALS trial_result · 2024-04-23
  Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial [Phase 2]

  A Phase 2 clinical trial evaluating IMB-1018972 for safety, tolerability, and efficacy in non-obstructive hypertrophic cardiomyopathy has co…

• CLINICAL_TRIALS trial_result · 2022-08-09
  Clinical Trial Update: A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) [Phase 2]

  Phase 2 study of mavacamten in adults with symptomatic non-obstructive hypertrophic cardiomyopathy has completed with results posted in 2022…

• CLINICAL_TRIALS trial_result · 2014-12-19
  Clinical Trial Update: Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy [NA]

  A completed clinical trial evaluating continuous positive airway pressure (CPAP) in patients with hypertrophic cardiomyopathy, including bot…